Free Trial

iRhythm Technologies (IRTC) Stock Price, News & Analysis

-1.17 (-1.32%)
(As of 05/28/2024 ET)
Today's Range
50-Day Range
52-Week Range
281,669 shs
Average Volume
423,839 shs
Market Capitalization
$2.73 billion
P/E Ratio
Dividend Yield
Price Target

iRhythm Technologies MarketRank™ Stock Analysis

Analyst Rating
3.00 Rating Score
52.7% Upside
$134.00 Price Target
Short Interest
9.84% of Shares Sold Short
Dividend Strength
News Sentiment
1.43mentions of iRhythm Technologies in the last 14 days
Based on 5 Articles This Week
Insider Trading
Selling Shares
$4.27 M Sold Last Quarter
Proj. Earnings Growth
From ($3.22) to ($2.14) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.31 out of 5 stars

Medical Sector

771st out of 931 stocks

Surgical & Medical Instruments Industry

87th out of 101 stocks

IRTC stock logo

About iRhythm Technologies Stock (NASDAQ:IRTC)

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

IRTC Stock Price History

IRTC Stock News Headlines

iRhythm Technologies (NASDAQ:IRTC) Shares Down 3.7%
iRhythm Technologies Inc
The Analyst Landscape: 4 Takes On iRhythm Technologies
Q1 2024 iRhythm Technologies Inc Earnings Call
See More Headlines
Receive IRTC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iRhythm Technologies and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical & medical instruments
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Rating Score (0-4)
Research Coverage
7 Analysts


Net Income
Pretax Margin


Sales & Book Value

Annual Sales
$492.68 million
Book Value
$6.85 per share


Free Float
Market Cap
$2.73 billion
(Almost) Everything You Need To Know About The EV Market Cover

Click the link below and we'll send you MarketBeat's guide to investing in electric vehicle technologies (EV) and which EV stocks show the most promise.

Get This Free Report

IRTC Stock Analysis - Frequently Asked Questions

Should I buy or sell iRhythm Technologies stock right now?

7 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for iRhythm Technologies in the last twelve months. There are currently 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" IRTC shares.
View IRTC analyst ratings
or view top-rated stocks.

What is iRhythm Technologies' stock price target for 2024?

7 analysts have issued 1 year target prices for iRhythm Technologies' stock. Their IRTC share price targets range from $110.00 to $165.00. On average, they anticipate the company's stock price to reach $134.00 in the next twelve months. This suggests a possible upside of 52.7% from the stock's current price.
View analysts price targets for IRTC
or view top-rated stocks among Wall Street analysts.

How have IRTC shares performed in 2024?

iRhythm Technologies' stock was trading at $107.04 on January 1st, 2024. Since then, IRTC shares have decreased by 18.0% and is now trading at $87.77.
View the best growth stocks for 2024 here

When is iRhythm Technologies' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 1st 2024.
View our IRTC earnings forecast

How were iRhythm Technologies' earnings last quarter?

iRhythm Technologies, Inc. (NASDAQ:IRTC) released its quarterly earnings data on Thursday, May, 2nd. The company reported ($1.47) earnings per share for the quarter, missing the consensus estimate of ($0.99) by $0.48. The business had revenue of $131.93 million for the quarter, compared to analyst estimates of $128.87 million. iRhythm Technologies had a negative net margin of 25.33% and a negative trailing twelve-month return on equity of 69.87%.

What guidance has iRhythm Technologies issued on next quarter's earnings?

iRhythm Technologies issued an update on its FY 2024 earnings guidance on Friday, May, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $578.0 million-$588.0 million, compared to the consensus revenue estimate of $580.8 million.

What is Kevin M. King's approval rating as iRhythm Technologies' CEO?

20 employees have rated iRhythm Technologies Chief Executive Officer Kevin M. King on Kevin M. King has an approval rating of 91% among the company's employees. This puts Kevin M. King in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of iRhythm Technologies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other iRhythm Technologies investors own include NVIDIA (NVDA), Alibaba Group (BABA), Salesforce (CRM), Block (SQ), Teladoc Health (TDOC), Trade Desk (TTD), Advanced Micro Devices (AMD), Intel (INTC), Broadcom (AVGO) and Boeing (BA).

When did iRhythm Technologies IPO?

iRhythm Technologies (IRTC) raised $76 million in an IPO on Thursday, October 20th 2016. The company issued 5,400,000 shares at $13.00-$15.00 per share. J.P. Morgan and Morgan Stanley acted as the underwriters for the IPO and Canaccord Genuity and BTIG were co-managers.

Who are iRhythm Technologies' major shareholders?

iRhythm Technologies' stock is owned by a variety of institutional and retail investors. Top institutional investors include Vanguard Group Inc. (9.48%), Capital Research Global Investors (8.02%), Blair William & Co. IL (2.68%), Champlain Investment Partners LLC (1.85%), BNP PARIBAS ASSET MANAGEMENT Holding S.A. (1.65%) and Westfield Capital Management Co. LP (1.62%). Insiders that own company stock include Daniel G Wilson, David A Vort, Douglas Devine, Kevin M King, Mark J Day, Merz Cathleen Noel Bairey, Patrick Michael Murphy and Quentin S Blackford.
View institutional ownership trends

How do I buy shares of iRhythm Technologies?

Shares of IRTC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:IRTC) was last updated on 5/28/2024 by Staff

From Our Partners